Medical Condition News

RSS

Dana-Farber doctor hosts live program on Twitter to discuss head and neck cancers

The recent news that Michael Douglas has been diagnosed with stage 4 throat cancer has raised public awareness of head and neck cancer. What causes throat cancer and what are the symptoms? Are there ways to prevent or reduce the risk of throat cancer? How is the human papillomavirus (HPV) related to oral cancer?

14 Sep 2010

Cetaphil launches Restoraderm for management of eczema and atopic dermatitis skin

The Cetaphil® brand, the #1 dermatologist-recommended brand of cleansers and moisturizers announced the launch of Cetaphil® Restoraderm® products, formulated specifically for the needs of eczema and atopic dermatitis skin. Cetaphil® Restoraderm® Skin Restoring Body Wash and Skin Restoring Moisturizer soothes itching associated with skin affected by eczema and atopic dermatitis.

14 Sep 2010

CSC launches new educational program to enhance lymphoma patient, physician communication

The Cancer Support Community (CSC), uniting The Wellness Community and Gilda's Club Worldwide, announced today the launch of Framing Life With Lymphoma, a new educational program designed to enhance lymphoma patient and physician communication.

14 Sep 2010

GenVec completes initial milestone in collaboration with Novartis

GenVec, Inc. today announced that it has achieved the first milestone in its collaboration with Novartis, related to the development of treatments for hearing loss and balance disorders. The milestone was triggered by the successful completion of certain preclinical development activities.

14 Sep 2010

Data from Phase II trial of zanolimumab in PTCL published in British Journal of Haematology

TenX Biopharma, Inc. announced today that data from a Phase II trial of zanolimumab (HuMax-CD4®) in peripheral T-cell Lymphoma were published in the British Journal of Haematology (Sep 2010: 150(5):565-73). The Hx-CD4-109 trial was designed to evaluate the safety and efficacy of zanolimumab in patients who have relapsed or refractory non-cutaneous peripheral T-cell lymphoma.

14 Sep 2010

Gentium announces defibrotide presentations at 33rd World Congress of International Society of Hematology

Gentium S.p.A. today announced that two posters and one oral presentation on defibrotide will be presented at the 33rd World Congress of International Society of Hematology to be held at the ICC Jerusalem International Convention Center in Jerusalem, Israel, October 10-13, 2010.

14 Sep 2010

Enrollment in Derma Sciences DSC127 Phase 2 trial in diabetic foot ulcer healing to conclude September end

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.

14 Sep 2010

Mini-Psych School 2010 program to focus on mental health in children, youth

For the past five years, the Douglas Mental Health University Institute has been offering the Mini-Psych School, the only public education program of its kind in Quebec. This year, the program will be focussing on mental health in children and youth.

14 Sep 2010

World Congress on Arthrosis to take place in Belgium from September 23 to 26, 2010

Over a 1000 experts from the world will participate in the Osteoarthritis Research Society International (OARSI) congress, under the Presidency of the Belgian Professor Yves Henrotin (University of Liège).

14 Sep 2010

CRA appeals to FDA for name change allowance in high fructose corn syrup labeling

In an effort to help clarify the labeling of food products for consumers, the Corn Refiners Association (CRA) today petitioned the U.S. Food and Drug Administration (FDA) to allow manufacturers the option of using 'corn sugar' as an alternative name for high fructose corn syrup.

14 Sep 2010

Over half of men surveyed believe erectile dysfunction as a symptom of overall health

A new poll of men and women over 50 years old reveals that, while most men report some level of erectile dysfunction (ED), women generally aren't aware of the problem in their partners. The problem extends beyond simple communication since ED can often be a symptom of overall health and well-being in men.

14 Sep 2010

VBL Therapeutics' VB-201 candidate delays onset of EAE, shows potential for MS, CNS treatment

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced the publication of preclinical data in the Journal of Neuroimmunology finding that its lead development candidate VB-201 significantly delayed the onset and severity of experimental autoimmune encephalomyelitis (EAE) in mice, the commonly used Multiple sclerosis.

14 Sep 2010

TransPharma Medical completes ViaDerm-GLP1 agonist Phase 1a trial for type II diabetes

TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1a trial of ViaDerm-GLP1 agonist which is being developed for the treatment of diabetes mellitus type II.

14 Sep 2010

Convergent Procedure for AF highlighted at EACTS 2010

The Convergent Procedure, a novel approach to treat atrial fibrillation (AF), enabled by epicardial ablation products from nContact Surgical, Inc., was highlighted at the Techno-College Atrial Fibrillation Session of the EACTS (European Association for Cardio-Thoracic Surgery) Annual Meeting in Geneva, Switzerland. More than 1,000 medical professionals attended the 2010 Techno-College Programme to receive an update on the latest technical advancements in cardiothoracic surgery.

14 Sep 2010

Cell-enriched primary renal cells improve survival and augment kidney function in CKD rodents

Tengion, Inc., a leader in regenerative medicine, announced today the publication of a key study in the American Journal of Physiology Renal Physiology by researchers at Tengion. In the study, rodents with chronic kidney disease (CKD) were treated with healthy kidney cells to catalyze the regeneration of functional kidney tissue and delay disease progression, as evidenced by extended survival, improved kidney filtration, and reduced severity of kidney tissue pathology.

14 Sep 2010

Researchers focus on finding markers to detect atypical vascular lesions that lead to angiosarcomato

Physicians have long noticed that breast cancer patients who have had surgery or radiation therapy have an heightened risk of developing angiosarcoma, a rare type of cancer that originates in the lining of the blood vessels.

14 Sep 2010

NCCN Oncology Policy Summit focuses on off-label use of drugs and biologics

The National Comprehensive Cancer Network (NCCN) announced today that key policy organizations and thought leaders will convene to discuss the critically important subject of the use of drugs and biologics for indications that are supported by evidence and compendia, but that are beyond the indications listed in the FDA label. This invitation-only Policy Summit will be held on December 17, 2010 at the National Press Club in Washington DC.

14 Sep 2010

Notch1 protein impacts childhood leukemia progression: Study

A protein crucial for the immune response appears to be a key player in the progression of a devastating form of childhood leukemia called T-cell acute lymphoblastic leukemia (T-ALL). Suppressing the activity of the protein kills the leukemic cells, the study shows, opening a potential avenue to new drugs that could prevent progression of the disease.

14 Sep 2010

BC-CfE study finds links between insite use, addiction treatment and stopping injection drug use

A study led by researchers at the BC Centre for Excellence in HIV/AIDS (BC-CfE) at St. Paul's Hospital and the University of British Columbia has found that supervised injection facilities such as Vancouver's Insite connect clients with addiction treatment, which in turn resulted in greater likelihood of stopping injection drug use for at least six months.

14 Sep 2010

Sorghum bran contains high antioxidant, anti-inflammatory properties: Study

A new University of Georgia study has found that select varieties of sorghum bran have greater antioxidant and anti-inflammatory properties than well-known foods such as blueberries and pomegranates.

14 Sep 2010

Medical Condition News

Dana-Farber doctor hosts live program on Twitter to discuss head and neck cancers

Cetaphil launches Restoraderm for management of eczema and atopic dermatitis skin

CSC launches new educational program to enhance lymphoma patient, physician communication

GenVec completes initial milestone in collaboration with Novartis

Data from Phase II trial of zanolimumab in PTCL published in British Journal of Haematology

Gentium announces defibrotide presentations at 33rd World Congress of International Society of Hematology

Enrollment in Derma Sciences DSC127 Phase 2 trial in diabetic foot ulcer healing to conclude September end

Mini-Psych School 2010 program to focus on mental health in children, youth

World Congress on Arthrosis to take place in Belgium from September 23 to 26, 2010

CRA appeals to FDA for name change allowance in high fructose corn syrup labeling

Over half of men surveyed believe erectile dysfunction as a symptom of overall health

VBL Therapeutics' VB-201 candidate delays onset of EAE, shows potential for MS, CNS treatment

TransPharma Medical completes ViaDerm-GLP1 agonist Phase 1a trial for type II diabetes

Convergent Procedure for AF highlighted at EACTS 2010

Cell-enriched primary renal cells improve survival and augment kidney function in CKD rodents

Researchers focus on finding markers to detect atypical vascular lesions that lead to angiosarcomato

NCCN Oncology Policy Summit focuses on off-label use of drugs and biologics

Notch1 protein impacts childhood leukemia progression: Study

BC-CfE study finds links between insite use, addiction treatment and stopping injection drug use

Sorghum bran contains high antioxidant, anti-inflammatory properties: Study

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News